Subtotal: KSh17,500.00
Welcome to Oak Peptides. Kenya's Trusted Peptide & Biotechnology Partner
KSh13,000.00
In Stock
Semaglutide is a GLP-1 (Glucagon-Like Peptide-1) receptor agonist that has become one of the most widely recognized peptide-based therapies for metabolic health. It works by mimicking the body’s natural GLP-1 hormone, helping regulate blood sugar levels, appetite, and food intake.
Semaglutide has been approved in various formulations for type 2 diabetes management and chronic weight management in appropriate patient populations.
Semaglutide targets GLP-1 receptors throughout the body and brain.
Semaglutide acts on areas of the brain involved in appetite regulation, helping reduce hunger and caloric intake.
The peptide stimulates insulin secretion and reduces glucagon release in a glucose-dependent manner, helping support blood sugar management.
Semaglutide slows stomach emptying, which can contribute to increased feelings of fullness after meals.
Clinical studies have shown significant reductions in body weight when semaglutide is combined with lifestyle interventions.
Semaglutide is used to improve glycemic control in adults with type 2 diabetes.
The FDA has approved semaglutide (Wegovy) for reducing the risk of major cardiovascular events in certain adults with obesity or overweight and cardiovascular disease.
Research continues to explore semaglutide’s role in metabolic health, insulin sensitivity, and related conditions.
✔ Appetite Control
✔ Once-Weekly Administration
✔ Blood Sugar Support
✔ Weight Management Support
✔ Metabolic Health Optimization
✔ Clinically Studied GLP-1 Technology
Semaglutide is among the most extensively studied GLP-1 receptor agonists available today. Its long half-life allows for once-weekly dosing, making it a convenient option for many patients.
Semaglutide is a GLP-1 receptor agonist that mimics a naturally occurring hormone involved in appetite regulation and blood sugar control.
Most injectable formulations are administered once weekly.
Its extended half-life, strong clinical evidence base, and effects on both glucose regulation and appetite have made it one of the most prominent GLP-1 therapies globally.
At Oak Peptides Pharmaceuticals, we are committed to providing premium-quality peptide solutions backed by scientific innovation, professional support, and a dedication to excellence.
🧬 Premium Quality Standards
🔬 Advanced Biotechnology
💎 Scientific Excellence
🚚 Nationwide Delivery
🤝 Expert Customer Support
Reviews
There are no reviews yet.